2don MSN
Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis ...
While Trump's tariffs could have a broad impact on healthcare prices, it is likely they will not have the devastating result ...
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...
She learned that she would have to try, and "fail," on two other drugs before Medicare would cover the new one.
We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...
U.S. Senator Tammy Baldwin (D-WI) joined a group of her colleagues in introducing the Capping Prescription Costs Act, ...
Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...
Recently, a letter to the editor I wrote was published in the Arkansas Democrat-Gazette on the subject of skyrocketing health-care costs, inclusive of rising pharmaceutical drug prices. I referenced ...
Most Americans would prefer brand-name drugs—but end up buying generic versions because of the cost, new consumer research ...
U.S. Sen. Kirsten Gillibrand is proposing legislation to reduce the cost of prescription drugs. The Capping Prescription ...
Senator Kirsten Gillibrand announced the Capping Prescription Costs Act, which would limit annual out-of-pocket drug expenses ...
"So, for the most part, we're talking about drugs and devices, which are, at most, about a quarter of healthcare spending." "In terms of prices for the industry, whether it's absorbed in their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results